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 A BSTRACT 
 Chitosan-coated alginate microspheres prepared by emulsifi -
cation/internal gelation were chosen as carriers for a model 
protein, hemoglobin (Hb), owing to nontoxicity of the poly-
mers and mild conditions of the method. The infl uence of 
process variables related to the emulsifi cation step and micro-
sphere recovering and formulation variables, such as alginate 
gelation and chitosan coating, on the size distribution and 
encapsulation effi ciency was studied. The effect of micro-
sphere coating as well its drying procedure on the Hb release 
profi le was also evaluated. Chitosan coating was applied by 
either a continuous microencapsulation procedure or a 
2-stage coating process. Microspheres with a mean diameter 
of less than 30 μm and an encapsulation effi ciency above 
90% were obtained. Calcium alginate cross-linking was 
optimized by using an acid/CaCO 3 molar ratio of 2.5, and 
microsphere-recovery with acetate buffer led to higher 
encapsulation effi ciency. Hb release in gastric fl uid was 
minimal for air-dried microspheres. Coating effect revealed 
a total release of 27% for 2-stage coated wet microspheres, 
while other formulations showed an Hb release above 50%. 
Lyophilized microspheres behaved similar to wet micro-
spheres, although a higher total protein release was obtained 
with 2-stage coating. At pH 6.8, uncoated microspheres 
dissolved in less than 1 hour; however, Hb release from 
air-dried microspheres was incomplete. Chitosan coating 
decreased the release rate of Hb, but an incomplete release 
was obtained. The 2-stage coated microspheres showed no 
burst effect, whereas the 1-stage coated microspheres per-
mitted a higher protein release. 
 K EYWORDS:  alginate ,  chitosan ,  internal gelation ,  oral 
protein delivery ,  microspheres 
 INTRODUCTION 
 Oral administration of peptidic drugs is of great interest, but 
diffi culties associated with the poor permeability across 
biological membranes, susceptibility to enzymatic attack, 
rapid postabsorptive clearance, and chemical instability 
have thwarted efforts to achieve an effi cient formulation. 1 
Several approaches have been proposed to improve oral 
bioavailability, among them microencapsulation, which 
represents a promising concept. 2 A mild encapsulation 
method should be adopted to minimize protein denaturation 
and the loss of its biological activity, avoiding exposure to 
high temperatures and organic solvents. 
 The relatively mild cross-linking conditions required for 
obtaining chitosan-coated alginate microparticles and the 
nontoxicity and biodegradability of these 2 naturally occur-
ring biopolymers have enabled them to be used for the 
encapsulation of a wide variety of biologically active agents 
including proteins, 3-13 enzymes, 14-16 antibodies, 17 cells, 18-23 
and DNA. 24-27 
 Alginate is an anionic copolymer of 1,4-linked- b -D-
 mannuronic acid and  a -L-guluronic acid residues. In the 
presence of divalent cations such as calcium, alginate forms 
a gel due to the stacking of guluronic acid (G) blocks with 
the formation of  “ egg-box ” calcium-linked junctions. 28 
Alginate gel microspheres have been conventionally pre-
pared using extrusion by dropping an alginate solution 
through a needle into a CaCl 2 solution (external gelation), 
but this approach has several inconveniences, namely, the 
limitation in reducing microsphere diameter, the teardrop 
shape of the microparticles produced, and the diffi culty in 
industrial scale-up. 29 The use of an emulsifi cation/external 
gelation method by adding an emulsion of alginate solution 
in a hydrophobic phase to a CaCl 2 solution 30 , 31 could permit 
the reduction of microparticle diameter, but the disruption 
of the emulsion system equilibrium may cause defi cient 
diameter control and a signifi cant degree of clumping of 
microspheres. 32 Emulsifi cation/internal gelation is another 
alternative to extrusion in which the bead diameter can be 
easily controlled and that has scale-up potential. 33 In this 
method, an alginate solution containing an insoluble cal-
cium salt is dispersed in oil, and gelation is achieved by 
gentle acidifi cation with an oil-soluble acid that causes cal-
cium ion release. 34 The production of internally gelled algi-
nate microspheres has also been accomplished by extruding 
an alginate solution mixed with CaCO 3 dropwise through a 
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syringe needle into an oil containing an oil-soluble acid 35 ; 
however, in this case the inconvenience related to extrusion/
external gelation was also verifi ed. 
 To reduce the porosity and increase stability, alginate mi -
croparticles have been coated with chitosan by electrostatic 
interaction. 36 The negatively charged carboxylic acid groups 
of alginate bind ionically with positively charged amino 
groups of chitosan, a cationic polymer, to form a polyelec-
trolyte complex on the basis of their opposite charges. 37 
Moreover, chitosan has been reported to enhance absorption 
of various compounds across the mucosal barrier owing to 
its properties of mucoadhesion, which increase the contact 
time of the drug with the mucosa, and its ability to induce a 
transient opening of epithelial cell tight junctions. 38-40 
 Alginate microspheres prepared by internal gelation and 
cross-linked with chitosan were applied in the encapsula-
tion of DNA 24 , 26 , 27 and Sudan Orange G. 41 Encapsulation 
of bioactive compounds, such as proteins and DNA, by 
either internal gelation or external gelation revealed that 
in ternal gelation provides a better encapsulant protection 
from hydrolysis 24 but may permit higher losses from 
microspheres. 9 
 In the present study, hemoglobin (Hb) was used as a model 
protein for evaluating the infl uence of some process and 
formulation factors on the morphology and encapsulation 
effi ciency of calcium alginate microspheres obtained by 
emulsifi cation/internal gelation. The effect of microsphere 
coating as well as microsphere drying procedure on the 
encapsulation effi ciency, granulometry, and Hb release were 
also evaluated. Ideally, Hb should not be released in simu-
lated gastric pH, and a slow release within 3 to 5 hours 
should occur in simulated intestinal fl uid. 
 MATERIALS AND METHODS 
 Materials 
 Sodium alginate SG300 was supplied by SKW Biosystems 
(Paris, France). This alginate exhibits an average molecular 
weight (MW) of 694 kd and a high guluronic content of 
60%. 35 Low molecular weight (LMW) chitosan (150 kd) 
and Span 80 were purchased from Fluka Biochemika (Stein-
heim, Germany). Freeze-dried bovine hemoglobin (Hb) was 
obtained from Sigma (Steinheim, Germany). CaCO 3 was 
supplied by Omya (Orgon, France), and paraffi n oil and 
Tween 80 were supplied by Vaz Pereira (Lisbon, Portugal). 
All other chemicals used were of analytical reagent grade. 
 Methods 
 Preparation of Microspheres 
 Microspheres were prepared by emulsifi cation/internal 
gelation. 33 A 2% wt/vol sodium alginate solution with 1.5% 
wt/vol bovine Hb was prepared by dissolving alginate in a 
previously prepared protein solution in phosphate buffer at 
pH 6.8 ( United States Pharmacopeia [ USP ] XXVI). 
 Microspheres were prepared by adding a suspension of 5% 
wt/vol ultrafi ne CaCO 3 into the alginate solution. After 
homogenization, the mixture was dispersed into paraffi n oil 
containing, in some cases, a lipophilic surfactant (Span 80 
1% vol/vol) by stirring at a speed rate from 200 up to 600 
rpm using an Ika-Eurostar mixer (Staufen, Germany) with a 
marine impeller. The aqueous/oily phase ratio was varied 
from 20% to 40%, keeping the total volume constant. After 
a 15-minute emulsifi cation, 20 mL of paraffi n oil containing 
glacial acetic acid was added to the water/oil (w/o) emul-
sion, reducing the alginate pH to approximately 5.0, and 
stirring continued to permit CaCO 3 solubilization. The 
infl uence of the acetic acid/CaCO 3 molar ratio, a formula-
tion parameter, was evaluated (1.25 and 2.5) by changing 
the volume of acetic acid added to the w/o emulsion. Oil-
dispersed microspheres were recovered by using the follow-
ing washing media either with or without Tween 80 (1% 
vol/vol): CaCl 2 0.05 M, distilled water, and acetate buffer at 
pH 5.5 ( USP XXVI). Microspheres were successively 
washed with the same washing medium used in partition, 
until no more oil was detected under optical microscope 
observation. 
 Chitosan coating was applied using 2 methods: a continu-
ous microencapsulation procedure designated as 1-stage 
coating (C1), and a 2-stage procedure designated as 2-stage 
coating (C2). In the fi rst method, coating was performed by 
adding an emulsion of 0.1% wt/vol chitosan in 1% (vol/vol) 
acetic acid, at pH 6.4, in paraffi n oil (50/50 vol/vol), to the 
oily dispersed gelled microspheres after calcium solubiliza-
tion, and stirring was performed for 30 minutes. Coated 
microspheres were recovered by using acetate buffer at pH 
5.5, as described above. Two-stage coating method was per-
formed by adding a 0.1% wt/vol chitosan solution in 1% 
vol/vol acetic acid, at pH 6.4, to the isolated microspheres 
under magnetic stirring for 30 minutes. Uncoated (U) micro-
spheres were used as control. 
 Microspheres were kept in the washing medium to be used 
in the wet state (W). Otherwise, gelled microspheres were 
allowed to dry in air at 4ºC to 6ºC (D) until constant weight 
was achieved or microspheres were lyophilized (L). Lyoph-
ilization was performed at 0ºC for 48 hours (Lyph-lock 
6 apparatus, Labconco, Kansas City, MS) after freezing 
microspheres in an ethanol bath (Benchtop shell freezer, 
Freezone model 79490, Labconco) at  − 50ºC. 
 Microsphere Morphology 
 Microsphere morphology was monitored by optical micro-
scopic observation using an optical microscope Olympus 
BH2-UMA equipped with a Cue-2 image analyzer  (Olympus, 
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Tokyo, Japan). Granulometric size distribution based on 
volume distribution was determined in washing media by 
laser diffractometry (Fraunhofer model) using a Coulter 
LS130 particle analyzer (Beckman Coulter Inc., Fullerton, 
CA), with a size range from 0.1 to 1000  m m. Measurements 
were made in triplicate for each batch. 
 Encapsulation Effi ciency 
 The encapsulation effi ciency was evaluated by an indirect 
method. The nonencapsulated Hb was determined by mea-
suring its losses during microsphere preparation and recov-
ery. Protein retention was calculated from the difference 
between the initial amount of protein added and the total 
losses. 
 Hb Quantifi cation 
 Samples were mixed with NaOH to raise pH above 9.5 and 
ethanol was added (50/50 vol/vol) to the reaction mixture. 
The absorbance was measured at 401 nm (UV-1603, UV-
visible spectrophotometer, Shimadzu, Kyoto, Japan). When 
using 0.05 M CaCl 2 as the washing medium, 0.1 M ethyl-
enediamine tetra-acetic acid (EDTA) was added before 
adjusting the pH. A calibration curve was prepared for up to 
0.6 g/L of hemoglobin concentration. 
 In Vitro Release Studies 
 An amount of microspheres equivalent to 10 mg of Hb was 
placed in glass vials containing 50 mL of artifi cial gastric 
fl uid ( USP XXVI), without enzymes, under magnetic stir-
ring (100 rpm for 2 hours). Microspheres were then trans-
ferred into artifi cial intestinal fl uid ( USP XXVI), without 
enzymes. Samples were withdrawn at different time inter-
vals and spectrophotometrically assayed for the Hb concen-
tration as mentioned previously. Released Hb was calculated 
accordingly to the following equation: 
  Hb release = Mt Min ´ 100 (1)
 where  M t is the amount of Hb at time  t and  M in is the amount 
of Hb in the microspheres at time  t = 0. All studies were 
performed in triplicate. 
 RESULTS 
 Microsphere Morphology 
 A unimodal size distribution with a mean diameter less than 
30  m m was obtained for uncoated alginate microspheres 
prepared using a w/o ratio of 30/70, 1% emulsifi er, and 
mixer rotational speed of 400 rpm, and recovered with ace-
tate buffer. The microspheres were dispersed and spherical 
in shape as illustrated in  Figure 1 . 
 The effect of different process parameters on the mean size 
of microspheres was evaluated. Increasing the internal 
phase ratio from 20% to 40% resulted in a slight decrease in 
the mean size, and in the presence of Span 80 the micro-
sphere mean diameter decreased ( Table 1 ). The infl uence of 
the mixer rotational speed during the emulsifi cation step on 
size distribution ( Figure 2 ) was also evaluated, and it was 
shown that increasing the impeller rotational speed decreased 
the mean diameter of microspheres reaching a minimum at 
500 rpm. At 600 rpm, a lower mode value was obtained, but 
a broader distribution increased the mean size. At 400 rpm, 
the standard deviation relative to the mean was 46% and at 
600 rpm this value increased to 80%. 
 Microsphere recovery medium was determinant on micro-
sphere size distribution ( Table 2 ). Water-washed micro-
spheres presented a mean size that increased up to 200  m m 
and a broader and bimodal granulometric distribution. An 
increased mean size was also verifi ed for microspheres 
washed with CaCl 2 . Detergent-containing media did not 
cause signifi cant differences except for acetate buffer-
washed microspheres, which presented a higher mean diam-
eter and a broader distribution. These results, based on 
volume distribution, were different when a number distribu-
tion was used ( Figure 3 ). Microspheres washed with CaCl 2 
 Figure 1.  Optical photomicrograph of Hb-loaded alginate 
microspheres (magnifi cation 200 X). 
 Table 1.  Volume Mean Diameter of Microspheres in Relation to 
the Aqueous/Oily Phases Ratio and the Inclusion of a Surface 
Agent* 
Water/Oil (%) 
(vol/vol)
Span 80 1% 
(vol/vol) Diameter (  m)
20 +  26.0 ± 9.7
30 +  24.9 ± 11.6
40 +  22.7 ± 9.8
30 -  132.6 ± 36.8
 *Microspheres were prepared at 400 rpm. Data are shown as mean ± SD. 
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or water presented a smaller peak mode than acetate buffer-
recovered microspheres. 
 Formulation parameters also affected the microspheres’ mean 
diameter ( Table 3 ). Acetic acid/CaCO 3 molar ratio deter-
mines the degree of alginate gelation, and the microspheres’ 
mean size increased with the volume of acetic acid added to 
the emulsifi ed droplets of alginate. Chitosan-coated micro-
spheres presented a higher mean diameter size than uncoated 
microspheres due to aggregation during the coating process 
( Figure 4 ). During 2-stage coating, aggregation was more 
intense, leading to irregularly shaped units sizing above 1000 
 m m, which could not be measured by laser diffractometry. 
 After air drying, the macroscopic appearance of micro-
spheres was altered. Uncoated microspheres formed a fi lm, 
and clumps of microspheres were formed for coated micro-
spheres, probably owing to cohesion of the initially wet 
microspheres. 31 Lyophilized microspheres presented a 
sponge-like structure. 
 Encapsulation Effi ciency 
 Hb-loaded microspheres prepared by emulsifi cation/inter-
nal gelation retained more than 90% of the initial Hb inside 
the alginate microspheres. 
 Process parameters such as mixer rotational speed and con-
centration of emulsifi er did not affect Hb retention inside 
microspheres ( Tables 4 and  5 ). Varying the w/o phase ratio 
from 20% to 40% caused only a slight decrease in encapsu-
lation effi ciency. 
 Hb losses during preparation were minimal when recovery 
was performed either with acetate buffer or with water 
( Figure 5 ). Losses occurred preferentially during the fi rst 
wash, immediately after the partition, corresponding to Hb 
released during alginate gelation. CaCl 2 -recovered micro-
spheres registered signifi cant protein loss with an encapsu-
lation effi ciency less than 40%. Detergent-containing media 
signifi cantly increased protein leakage from microspheres 
when water or acetate buffer were used. 
 Taking into consideration the reaction between acetic acid 
and CaCO 3 , each mole of CaCO 3 reacts with 2 moles of 
CH 3 COOH. Using an acetic acid/CaCO 3 molar ratio slightly 
higher than stoichiometric proportion (2.5/1) resulted in 
high encapsulation effi ciencies, close to 90% ( Table 6 ). 
When an insuffi cient volume of acetic acid was used to dis-
solve the CaCO 3 (1.25/1 ratio) higher protein losses were 
observed. 
 One-stage coating did not signifi cantly change Hb encapsu-
lation effi ciency, in comparison to uncoated microspheres 
 Figure 2.  Volume mean diameter of microspheres formed at 
different mixer rotational speed. Error bars represent SD of the 
mean. 
 Table 2.  Volume Mean Diameter of Microspheres Recovered in 
Relation to the Microsphere Washing Medium* 
Washing Medium
Tween 80 1% 
(vol/vol) Diameter (  m)
CaCl 2 0.05 M  -  206.2 ± 108.4
 +  196.0 ± 112.9
Water  -  198.0 ± 143.7
 +  181.3 ± 135.9
Acetate buffer, pH 5.5  -  24.9 ± 11.6
 +  36.6 ± 17.8
 *Microspheres were prepared with an aqueous/oily phase of 30% 
(vol/vol) at 400 rpm. Data are shown as mean ± SD. 
 Figure 3.  Number size distribution of microspheres recovered 
using different washing medium: CaCl 2 0.05 M (), water (), 
and acetate buffer pH 5.5 (·). 
 Table 3.  Effect of Acetic Acid/CaCO 3 Molar Ratio on Volume 
Mean Diameter of Uncoated and Coated Microspheres* 
Acetic Acid/CaCO 3 
Molar Ratio Chitosan Coating Diameter (  m)
1.25  Uncoated  18.1 ± 9.5
2.5  Uncoated  24.9 ± 11.6
2.5  1-stage  150.8 ± 85.0
2.5  2-stage  >1000 † 
 *Microspheres were prepared with an aqueous/oily phase of 30% 
(vol/vol) at 400 rpm. Data are shown as mean ± SD. 
 † Obtained value was above the detection limit. 
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( Table 6 ). Hb losses during the 2-stage coating procedure 
were insignifi cant. 
 In Vitro Release Studies 
 The infl uence of chitosan coating and drying conditions of 
microspheres were evaluated on the release behavior of Hb 
in gastrointestinal simulated pH. The formulations used in 
the in vitro release studies are summarized in  Table 7 . 
 After 2-hour incubation at pH 1.2, a high release of Hb was 
obtained for W and L microspheres, while for air-dried 
microspheres a lower Hb release was obtained ( Table 8 ). 
During assay, UD and C1D microspheres did not disperse 
completely and, in the case of C2D microspheres, a partial 
dispersion of microspheres occurred after 30 minutes. 
 Coating infl uence on Hb retention, at pH 1.2, was observed 
for the C2W and C1D microspheres, where protein released 
was lower compared with uncoated formulations. One-stage 
coating caused a higher retention of Hb for D and L micro-
spheres compared with C2 microspheres, and for W micro-
spheres the opposite occurred. 
 In intestinal simulated fl uid ( Figures 6 ,  7 , and  8 ), a burst effect 
was observed for uncoated microspheres, although a lower 
effect was detected for UD microspheres. A fast Hb release 
(<1 hour) occurred in the UW and UL microspheres. Some 
microsphere fragments persisted for UD microspheres until 
the end of the assay, which prevented a complete Hb release. 
 Coating microspheres decreased the release rate of Hb, at 
pH 6.8, but an incomplete release was obtained. C2W 
microspheres released less than 10% of encapsulated Hb, 
while the C1W microspheres, showing a slight burst effect, 
released almost 20%. C2D microspheres showed a similar 
release profi le to that obtained for C2W microspheres. C1D 
microspheres changed its behavior completely compared to 
 Figure 4.  Optical photomicrograph of (A) 1-stage and (B) 2-
stage chitosan-coated alginate microspheres (magnifi cation 200 
X and 100 X for A and B, respectively). 
 Table 4.  Encapsulation Effi ciency of Hemoglobin in Relation to 
the Emulsion Formulation Parameters* 
Water/Oil 
(%) (vol/vol)
Span 80 1% 
(vol/vol)
Hb Losses During 
First Wash (%)
Encapsulation 
Effi ciency (%)
20  +  6.0  92.9
30  +  7.6  90.9
40  +  9.1  88.9
30  -  8.2  91.2
30  +  7.6  90.9
 *The rotational impeller speed was 400 rpm. Data represent the 
average of 3 replicates. 
 Table 5.  Effect of the Rotational Impeller Speed on Hemoglobin 
Encapsulation Effi ciency* 
Speed Rate (rpm)
Hb Losses During 
 First Wash (%)
Encapsulation 
Effi ciency (%)
200  7.1  90.9
300  7.8  91.9
400  7.6  90.9
500  14.6  84.3
600  5.5  92.8
 *Microspheres were prepared with an aqueous/oily phase ratio of 30% 
(vol/vol) at 400 rpm. Data represent the average of 3 replicates. 
 Figure 5.  Hemoglobin losses from microspheres during the fi rst 
wash (black) and subsequent washes (gray) with washing media 
either with (T) or without Tween 80 1% (vol/vol). 
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C1W microspheres, releasing less than 5% of Hb after 
6 hours at pH 6.8. Hb release from C2L microspheres was 
reduced (less than 2%), and an incomplete total release of 
65% was achieved. For C1L microspheres, a higher Hb 
release was observed, but the fi nal value after 6 hours, 70%, 
was not signifi cantly different from that obtained for micro-
spheres coated in 2 stages. 
 DISCUSSION 
 Microsphere Morphology 
 Microsphere size was kept to a minimum to improve the 
surface area contact. Alginate bioadhesive 42 and chitosan 
mucoadhesive properties 43 as well as the polycation ability 
to enhance the paracellular absorption through the intestinal 
membrane 38 are favored by a more intimate contact between 
intestinal mucosa and smaller-sized microspheres. 
 The formation of carbon dioxide is inherent to the internal 
gelation method used in this work, where calcium is obtained 
by acid-induced solubilization of a calcium insoluble com-
plex. One of the great concerns is the possibility of an 
increase in the alginate matrix porosity caused by the release 
of carbon dioxide, which may cause deformity and clump-
ing of microspheres. 32 In this study, spherical and discrete 
microspheres without agglomeration were obtained when 
an appropriate recovery medium was used. 
 Diameter distribution of microspheres obtained by emulsifi -
cation/internal gelation depends on the size of the emulsion 
droplets that are determined by a balance between the dis-
persive and the surface tension forces. 44 The former tends to 
disperse the emulsion and the latter causes coalescence. The 
interfacial tension between the alginate droplets and the oil 
in the continuous phase is reduced in the presence of Span 
80 and microsphere size is decreased. Increasing the disper-
sive force also decreased microsphere mean diameter, 
although a broader distribution was obtained, contributing 
to a higher heterogeneity of the batch. Mean size increased 
for an impeller rotational speed higher than 500 rpm, which 
could be explained by aggregation of small emulsion drop-
lets during the gelation induced by acid addition. Thus, an 
impeller rotational speed of 400 rpm was chosen to allow 
the achievement of small microspheres with a narrow size 
distribution. 
 The decrease of microsphere mean size with the proportion 
of dispersed phase can be attributed to the higher viscosity. 
Preliminary results 44 showed that a higher proportion of dis-
persed phase causes a large increase in mean size, justifi ed 
 Table 6.  Effect of Acetic Acid/CaCO 3 Molar Ratio on Hb 
Encapsulation Effi ciency for Uncoated and Coated 
Microspheres* 
Acetic Acid/
CaCO 3 Molar 
Ratio
Chitosan 
Coating
Hb Losses 
During First 
Wash (%)
Encapsulation 
Effi ciency (%)
1.25  Uncoated  20.1  65.2
2.5  Uncoated  7.6  90.9
2.5  1-stage  8.7  89.3
2.5  2-stage  7.6  90.9
 *Microspheres were prepared with an aqueous/oily phase ratio of 30% 
(vol/vol) at 400 rpm. Data represent the average of 3 replicates. 
 Table 7.  Formulations Used in the Release Studies Prepared 
Using Different Drying and Coating Processes* 
Coating Process
Drying Process
Wet Air Dried Lyophilized 
 Uncoated  UW  UD  UL
 1-step coated  C1W  C1D  C1L
 2-step coated  C2W  C2D  C2L
 *U indicates uncoated; W, wet state; D, air dried; L, lyophilized; C1, 
1-stage chitosan coated; and C2, 2-stage chitosan coated. 
 Table 8.  Hb Release After 2 Hours in Simulated Gastric Fluid 
From Uncoated (U), 1-stage Chitosan Coated (C1), and 2-stage 
Chitosan Coated (C2) Microspheres in the Wet State (W), 
Air-dried (D), or Lyophilized (L)* 
Hb Released in Simulated Gastric Fluid After 2 
Hours (%)
 W D L
U  60.7 ± 1.7  0.2 ± 0.3  49.6 ± 6.2
C2  27.5 ± 2.0  18.7 ± 8.4  62.6 ± 5.3
C1  68.4 ± 4.0  0.00  53.4 ± 0.7
 *W indicates wet state; D, air dried; L, lyophilized; U, uncoated; C2, 
2-stage chitosan coated; and C1, 1-stage chitosan coated. Data are 
shown as mean ± SD. 
 Figure 6.  In vitro release profi le of Hb in simulated gastric fl uid 
for 2 hours and then in simulated intestinal fl uid for ( ¨  ) uncoated, 
() 1-stage coated, and () 2-stage coated wet microspheres. Error 
bars represent SD of the mean based on 5 replicates. 
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by an increase in the frequency of coalescence resulting in 
the formation of aggregates, which was not verifi ed with the 
conditions used in this work. 
 Microspheres obtained by emulsifi cation/internal gelation 
are usually oil-separated by several washing cycles with a 
CaCl 2 solution containing Tween 80 1% (vol/vol). 35 , 41 
Among washing media tested to recover microspheres, 
water and CaCl 2 caused an increase in mean size and the 
appearance of a bimodal distribution attributed to aggrega-
tion of the recently formed microspheres during partition. 
Washing alginate microspheres with water or CaCl 2 proba-
bly causes water losses to the external medium. In the case 
of water, this effect is explained by its low osmolarity, which 
induces ion and, consecutively, water diffusion outside 
the microspheres. Recovering microspheres with CaCl 2 
increases the degree of alginate cross-linking, which is 
known to cause gel shrinkage. 45 These water losses may 
induce adhesion between microspheres resulting in the for-
mation of aggregates probably owing to the formation of 
new hydrogen bonds created between hydroxyl groups of 
the polymer. 46 The formation of new hydrogen bonds is 
apparently avoided in the case of acetate buffer, thus pre-
venting aggregation. This hypothesis is supported by the 
fact that when size distribution is analyzed in a number per-
spective, the peak mode decreases when water and CaCl 2 
are used as recovery media compared with acetate buffer at 
pH 5.5. The water losses cause a decrease in microsphere 
size, although the small microspheres tend to aggregate, 
leading to a higher mean size in volume distribution. The 
number of aggregates formed is very small compared with 
the number of discrete microspheres and, for this reason, 
the peak mode appears in the range of discrete microspheres 
when number distribution is considered. 
 The increase in acetic acid/CaCO 3 molar ratio, achieved by 
adding a higher volume of acid, increased the mean diame-
ter of microspheres. Theoretically, an inverse effect would 
be expected, since alginate gelation induced by calcium 
ions causes microsphere shrinkage and a decrease in size. 45 
For this reason, it is thought that microsphere granulometry 
could be infl uenced during microsphere recovery, and that 
acetate buffer at pH 5.5 continues the solubilization of 
CaCO 3 and therefore alginate gelation. In the absence of the 
oil barrier and in the case in which a lower acid/CaCO 3 
molar ratio was used, a higher effect probably took place. 
 Two-stage coated microspheres underwent a visible aggre-
gation during the coating process that occurred in lesser 
degree for C1 microspheres. Aggregation can be explained 
by strong electrostatic interaction between alginate and 
chitosan, 2 polyelectrolytes of opposite charge, which in 
the case of 1-stage coating is partially avoided by the pres-
ence of the external oil phase. 
 Encapsulation Effi ciency 
 Another concern related to the increase of alginate matrix 
porosity caused by the release of carbon dioxide during 
acid-induced solubilization of CaCO 3 consists of a possible 
increase in drug losses from microspheres. It was previously 
shown by Vandenberg et al 47 that internal gelation of algi-
nate results in reduced encapsulation effi ciency of the model 
protein bovine serum albumin (BSA) when compared with 
external gelation. In this study, high encapsulation effi -
ciency for Hb was obtained using emulsifi cation/internal 
gelation. Attempts were made to reduce protein losses dur-
ing the emulsifi cation step and also during microsphere par-
tition and washing. Phosphate buffer at pH 6.8 was used as 
the alginate dissolution medium to help protein retention 
during the emulsifi cation step. At this pH, Hb has a positive 
charge (pI 7.1), which favors the electrostatic interaction 
with the polyanionic alginate. This effect was previously 
 Figure 7.  In vitro release profi le of Hb in simulated gastric fl uid 
for 2 hours and then in simulated intestinal fl uid for ( ¨  ) 
uncoated, () 1-stage coated, and () 2-stage coated air-dried 
microspheres. Error bars represent SD of the mean based on 5 
replicates. 
 Figure 8.  In vitro release profi le of Hb in simulated gastric fl uid 
for 2 hours and then in simulated intestinal fl uid for ( ¨  ) 
uncoated, () 1-stage coated, and () 2-stage coated lyophilized 
microspheres. Error bars represent SD of the mean based on 5 
replicates. 
The AAPS Journal 2006; 7 (4) Article 88 (http://www.aapsj.org).
E910
described for the encapsulation of transforming growth fac-
tor-  1 (pI = 9.82) 48 and BSA 49 in alginate microspheres. 
 Microsphere recovery with CaCl 2 0.05 M conduced to low 
encapsulation effi ciency. The same effect was observed 
before with an external gelation method, where Hb-loaded 
alginate microspheres lost more than 90% of the protein to 
the CaCl 2 solution. 50 Microspheres did not retain the pro-
tein possibly owing to diffusion to the external medium; if 
ions are present in the free solution, then the protein (if elec-
trically not neutral) always fi nds enough counterions for 
charge compensation. 51 Using the internal gelation method, 
protein loss from alginate microspheres was reduced 
because Hb does not diffuse to the external oily medium. 
Thus, by choosing an appropriate partition medium, it was 
possible to control the diffusion of protein out of micro-
spheres and obtain high encapsulation effi ciencies. 
 A higher encapsulation effi ciency of Hb was obtained 
for acetate buffer – recovered microspheres because pH 
infl uences the degree of ionization of proteins and thus the 
interactions between proteins and polysaccharides of oppo-
site charge, 52 which may be responsible for increasing 
encapsulation effi ciency of proteins inside alginate mic-
roparticles. 4 , 48 , 49 Acetate buffer at pH 5.5 keeps alginate in 
its polyanionic state and Hb positively charged (pI = 7.1). 
Although Hb is instable at low pH, the dissociation only 
occurs at a pH below 5, 50 so acetate buffer should not inter-
fere with the protein integrity. 
 Washing microspheres with water also made it possible to 
obtain high protein retention. In this case, the absence of 
ions in the free solution may have minimized Hb diffusion 
to the washing media; however, mean size increased up to 
200  m m owing to microsphere aggregation. Therefore, ace-
tate buffer was selected as the most appropriate medium for 
microsphere partition and washing. 
 Other process parameters, related to the emulsifi cation step, 
such as mixer rotational speed, concentration of emulsifi er, 
and w/o ratio, did not cause great changes in protein reten-
tion, although it could be expected that factors favoring the 
increase of mean size could increase encapsulation effi ciency 
owing to a reduced surface area. Taking into account this 
fact, it can be assumed that encapsulation effi ciency is mainly 
determined during partition after destroying the oil barrier. 
 The increase of encapsulation effi ciency with increasing 
acetic acid/CaCO 3 molar ratio is explained by a higher 
extent of alginate gelation 53 that led to stronger micro-
spheres, providing a greater resistance to solute transport. 54 
 Coating microspheres with chitosan before partition did not 
prevent the small losses occurring after partition, which 
may indicate that these losses occurred during the gelation 
of microspheres induced by the addition of acid due to algi-
nate shrinkage. Further losses, as those verifi ed during 
external gelation process, are prevented by the dispersing-
oil medium. 
 In Vitro Release Studies 
 In acidic medium, calcium alginate matrices are depleted of 
calcium ions and converted to insoluble alginic acid within 
30 minutes without any visible changes in the morphol-
ogy. 55 This may reduce the gel strength favoring drug release 
by diffusion. Drug solubility in the medium is another 
important factor. Lipophilic encapsulates such as Sudan 
orange G 41 and slightly soluble drugs at acidic pH values 
such as nitrofurantoin 56 or sodium diclofenac 57 showed a 
minimal release after 1 to 2 hours under gastric conditions. 
After 2 hours at acidic pH values, soluble drugs such as 
nicardipine presented a release between 30% and 70%. 58 
For BSA, a protein model, with a molecular weight close to 
that of Hb, manufacture processes seemed very important in 
determining protein release after 24 hours of acid incuba-
tion. 47 For example, drying the microcapsules decreased 
protein release from 90% to 20%. 
 High Hb losses found at pH 1.2 can be attributed to an inter-
action existing at pH 5.5 between the negatively charged 
alginate and the positively charged Hb that is lost at pH 1.2 
with the partial precipitation of alginate in the form of 
alginic acid. At pH values lower than 4, Hb can easily be 
dissociated into dimers (MW = 32 000), and when the pH 
decreases further, Hb can be dissociated into monomers 
(MW = 16 000), which can diffuse more easily through the 
alginate-chitosan membrane than the tetramer. 59 
 As water is removed from the gel network during micro-
sphere drying, alginate concentration increases and average 
pore size is reduced. 47 , 60 When a high G alginate is used, 
microspheres reswell only slightly upon rehydration 61 and 
do not regain their initial diameter. A more pronounced 
effect is expected for air-dried microspheres since it was 
verifi ed that lyophilization of dextran-loaded alginate 
microspheres increased the release rate compared with heat-
dried microspheres. 62 The release rate decreased as the tem-
perature decreased, which may indicate that a slower drying 
rate reduces the pore size after rehydration. This fi nding is 
in accordance with the results obtained for U and C1 micro-
spheres, where the order for total Hb release after 2 hours at 
pH 1.2 was W > L > D. Hb release was prevented for UD 
and C1D microspheres because of the aggregates formed 
during the drying process that did not disperse when placed 
in acidic medium. 
 In the case of chitosan-coated microspheres, Hb needs to 
pass through a second layer of alginate-chitosan complex 
membrane to be released. The infl uence of chitosan coating 
on the encapsulate behavior, in gastric conditions, is still not 
clear. Chitosan-coated microspheres with a chitosan solu-
tion at 0.75% (wt/vol) showed the same drug retention after 
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24 hours of acid incubation as uncoated BSA-loaded mic-
roparticles, but decreasing chitosan concentration to 0.25% 
(wt/vol) offered a much higher retention. 47 In another study, 
with alginate microspheres prepared by emulsifi cation/
internal gelation, less than 10% of drug was released within 
the fi rst hour under gastric conditions for uncoated micro-
spheres, and after chitosan coating only a minimal release 
(less than 3%) was observed. 41 
 During 2-stage coating, a visible aggregation occurred that 
contributed to the higher retention of protein at pH 1.2 for 
C2W microspheres compared with UW and C1W micro-
spheres since the surface area for diffusion was reduced. 
The higher protein release obtained with C2 microspheres 
dried by air exposition or lyophilization compared with 
dried U and C1 microspheres is justifi ed by a destruction 
of the integrity of chitosan-alginate complex membrane 
by the drying process. A similar behavior was found for 
brilliant blue (BB) release in a saline solution. 63 For C1 
microspheres, the drying step contributed to the expected 
reduction in Hb release; it may be assumed that this coating 
process leads to a more stable membrane after drying. 
 Complete calcium alginate microsphere dissolution in intes-
tinal fl uid is due to the reduced Ca 2+ concentration within 
the microspheres after a 2-hour exposition to an acidic pH 48 
and to the sequestering of Ca 2+ ions of alginate network by 
the phosphate anions present in the dissolution medium. 28 
Hb release from UD microspheres was maximal at 1.5 hours 
and was followed by a slow release from some undissolved 
fragments of the fi lm formed during drying. The incomplete 
dissolution is due to a higher concentration of alginate 
obtained after microsphere drying. 3 
 Chitosan coating decreases drug release rate, and an incom-
plete release of Hb was obtained owing to suppression of 
erosion of alginate gel microspheres. 36 The initial burst 
effect observed for C1L and C1W microspheres, followed 
by a sustained release, is justifi ed by the presence of the 
alginate-chitosan complex membrane. C1D microspheres 
did not release Hb because the undispersed clumps obtained 
at acidic pH remained at pH 6.8, thereby decreasing the sur-
face area for diffusion. No burst effect was observed for C2 
microspheres after changing dissolution media, and only a 
small fraction of remaining Hb was released. One possible 
explanation is that the aggregation occurring between algi-
nate microspheres during the coating process may protect 
more from the pH infl uence in the alginate network due to a 
decreased surface area of exposition. 
 CONCLUSION 
 Hb-loaded alginate microspheres with a mean diameter less 
than 30  m m and an encapsulation effi ciency above 90% 
were prepared by an emulsifi cation/internal gelation method. 
Acetic acid/CaCO 3 molar ratio was important to obtain high 
encapsulation effi ciency, and microspheres recovered with 
acetate buffer made the control of protein diffusion out of 
microspheres easier, thus enabling the achievement of high 
encapsulation effi ciency with a narrow size distribution. 
 The in vitro release of Hb at simulated gastrointestinal con-
ditions from air-dried microspheres led to the lowest release 
at pH 1.2, whereas at pH 6.8 Hb release was fast for uncoated 
microspheres and incomplete for coated microspheres. 
Chitosan coating decreased the release rate at pH 6.8 and 
for 2-stage coating no burst effect occurred after changing 
dissolution media, although 1-stage coating permitted a 
higher total release of Hb. 
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